COGT
Price
$8.03
Change
-$0.10 (-1.23%)
Updated
Jan 17 closing price
Capitalization
887.01M
58 days until earnings call
QRON
Price
$0.17
Change
-$0.01 (-5.56%)
Updated
Jan 14 closing price
Capitalization
2.49M
Ad is loading...

COGT vs QRON

Header iconCOGT vs QRON Comparison
Open Charts COGT vs QRONBanner chart's image
Cogent Biosciences
Price$8.03
Change-$0.10 (-1.23%)
Volume$1.16M
Capitalization887.01M
Qrons
Price$0.17
Change-$0.01 (-5.56%)
Volume$5.53K
Capitalization2.49M
COGT vs QRON Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. QRON commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and QRON is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (COGT: $8.03 vs. QRON: $0.17)
Brand notoriety: COGT and QRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 70% vs. QRON: 92%
Market capitalization -- COGT: $887.01M vs. QRON: $2.49M
COGT [@Biotechnology] is valued at $887.01M. QRON’s [@Biotechnology] market capitalization is $2.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileQRON’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • QRON’s FA Score: 1 green, 4 red.
According to our system of comparison, QRON is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while QRON’s TA Score has 1 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 2 bearish.
  • QRON’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, COGT is a better buy in the short-term than QRON.

Price Growth

COGT (@Biotechnology) experienced а +2.42% price change this week, while QRON (@Biotechnology) price change was -5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

QRON is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($887M) has a higher market cap than QRON($2.49M). COGT YTD gains are higher at: 2.949 vs. QRON (-5.459). QRON has higher annual earnings (EBITDA): -343.38K vs. COGT (-256.4M). COGT has more cash in the bank: 336M vs. QRON (2.14K). QRON has less debt than COGT: QRON (382K) vs COGT (17.8M). COGT (0) and QRON (0) have equivalent revenues.
COGTQRONCOGT / QRON
Capitalization887M2.49M35,680%
EBITDA-256.4M-343.38K74,669%
Gain YTD2.949-5.459-54%
P/E RatioN/AN/A-
Revenue00-
Total Cash336M2.14K15,715,622%
Total Debt17.8M382K4,660%
FUNDAMENTALS RATINGS
COGT vs QRON: Fundamental Ratings
COGT
QRON
OUTLOOK RATING
1..100
3050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5159
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QRON's Valuation (3) in the null industry is significantly better than the same rating for COGT (80) in the Miscellaneous industry. This means that QRON’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (61) in the Miscellaneous industry is somewhat better than the same rating for QRON (100) in the null industry. This means that COGT’s stock grew somewhat faster than QRON’s over the last 12 months.

COGT's SMR Rating (98) in the Miscellaneous industry is in the same range as QRON (100) in the null industry. This means that COGT’s stock grew similarly to QRON’s over the last 12 months.

COGT's Price Growth Rating (51) in the Miscellaneous industry is in the same range as QRON (59) in the null industry. This means that COGT’s stock grew similarly to QRON’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as QRON (100) in the null industry. This means that COGT’s stock grew similarly to QRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTQRON
RSI
ODDS (%)
Bullish Trend 12 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
73%
Momentum
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
48%
MACD
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
35%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
29%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
89%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GDGSX28.320.22
+0.78%
Sit Global Dividend Growth S
UMBHX30.690.17
+0.56%
Carillon Scout Small Cap I
OTCIX32.180.12
+0.37%
MFS Mid Cap Growth I
RSEYX12.480.04
+0.32%
Columbia Global Value Inst2
LADPX21.300.06
+0.28%
Lord Abbett Developing Growth P

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.23%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
46%
Loosely correlated
+1.85%
KROS - COGT
43%
Loosely correlated
+3.23%
CYTOF - COGT
40%
Loosely correlated
+20.00%
MEOBF - COGT
39%
Loosely correlated
N/A
More

QRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, QRON has been loosely correlated with FDMT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if QRON jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QRON
1D Price
Change %
QRON100%
N/A
FDMT - QRON
39%
Loosely correlated
-2.14%
SNBIF - QRON
37%
Loosely correlated
N/A
RVMD - QRON
31%
Poorly correlated
+0.98%
INTI - QRON
24%
Poorly correlated
N/A
COGT - QRON
23%
Poorly correlated
-1.23%
More